← Leaderboards
Pembe Hande Ozdinler
Northwestern University At Chicago
$5,138,990
Attributed
$8,707,873
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,707,873 · 4
By mechanism
R01$7,844,930 · 2
R21$862,943 · 2
Top collaborators
- Richard B Silverman8 shared
- William L Klein2 shared
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsAlzheimer&AposLabelReporterEffective TherapyNeurodegenerative DisordersHereditary Spastic ParaplegiaAttentionBiologyProteinsTranslatingMotor NeuronsMotor Neuron DiseasePathway InteractionsAmyotrophic Lateral SclerosisMovementBrainIn VivoIn VitroPrimary Lateral SclerosisNerve DegenerationAffectCellsMulticatalytic Endopeptidase Complex
Grant awards (16)
Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimerâs disease and related dementias$1,401,127
R01 · FY2025 · AG · contact PI
Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimerâs disease and related dementias$1,536,774
R01 · FY2024 · AG · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$561,194
R01 · FY2023 · AG · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$609,584
R01 · FY2022 · AG · contact PI
Profiles of Common and Unique aspects of Upper Motor Neuron degeneration in HSP and ALS$440,000
R21 · FY2022 · NS · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$622,539
R01 · FY2021 · AG · contact PI
Administrative Supplement - Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$120,000
R01 · FY2021 · AG · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$635,495
R01 · FY2020 · AG · contact PI
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases$671,753
R01 · FY2019 · AG · contact PI
The role of UCHL1 on the health and stability of upper motor neurons$337,969
R01 · FY2017 · NS · contact PI
The role of UCHL1 on the health and stability of upper motor neurons$337,969
R01 · FY2016 · NS · contact PI
The role of UCHL1 on the health and stability of upper motor neurons$337,969
R01 · FY2015 · NS · contact PI
The role of UCHL1 on the health and stability of upper motor neurons$334,588
R01 · FY2014 · NS · contact PI
Genetic labeling and visualization of CSMN in models of motor neuron disorders$191,193
R21 · FY2014 · NS · contact PI
The role of UCHL1 on the health and stability of upper motor neurons$337,969
R01 · FY2013 · NS · contact PI
Genetic labeling and visualization of CSMN in models of motor neuron disorders$231,750
R21 · FY2013 · NS · contact PI